Your browser doesn't support javascript.
Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.
Syed, Mohamed Ahmed; Al Nuaimi, Ahmed Sameer; A/Qotba, Hamda Abdulla; Nasrallah, Gheyath K; Althani, Asmaa A; Yassine, Hadi M; Zainel, Abduljaleel Abdullatif; Khudadad, Hanan; Marji, Tamara; Veettil, Shajitha Thekke; Al-Jighefee, Hadeel T; Younes, Salma; Shurrab, Farah; Al-Sadeq, Duaa W; AlFehaidi, Al Anoud Saleh; Yfakhroo, Ameena Ibrahim; AlMesaifri, Meshal Abdulla; Al Mujalli, Hanan; Al Abdulla, Samya Ahmad; Al Kuwari, Mohamed Ghaith; Azad, Faruk Mohammed; Al Malki, Badria Ali Mohamed; Abdulmalik, Mariam Ali.
  • Syed MA; Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar. ahmed.sy3d@gmail.com.
  • Al Nuaimi AS; Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar.
  • A/Qotba HA; Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar.
  • Nasrallah GK; Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Althani AA; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Yassine HM; Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Zainel AA; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Khudadad H; Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Marji T; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Veettil ST; Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar.
  • Al-Jighefee HT; Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar.
  • Younes S; Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar.
  • Shurrab F; Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar.
  • Al-Sadeq DW; Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar.
  • AlFehaidi AAS; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Yfakhroo AI; Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar.
  • AlMesaifri MA; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Al Mujalli H; Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Al Abdulla SA; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Al Kuwari MG; Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Azad FM; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Al Malki BAM; Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar.
  • Abdulmalik MA; Department of Clinical Research, Primary Health Care Corporation, P.O. Box 26555, Doha, Qatar.
BMC Infect Dis ; 21(1): 645, 2021 Jul 05.
Artigo em Inglês | MEDLINE | ID: covidwho-1298045
ABSTRACT

BACKGROUND:

There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design and reports findings of a population based epidemiological study undertaken to characterise SARS-CoV2 in Qatar using limited resources in a timely manner.

METHODS:

Asymptomatic individuals ≥10 years registered with Qatar's publicly funded primary health provider were eligible. A stratified random sampling technique was utilized to identify the study sample. Participants were invited to an appointment where they completed a questionnaire and provided samples for polymerase chain reaction and Immunoglobulin M and G immunoassay tests. Data collected were analyzed to calculate point and period prevalence by sociodemographic, lifestyle and clinical characteristics.

RESULTS:

Of 18,918 individuals invited for the study, 2084 participated (response rate 10.8%). The overall point prevalence and period prevalence were estimated to be 1.6% (95% CI 1.1-2.2) and 14.6% (95% CI 13.1-16.2) respectively. Period prevalence of SARS-CoV2 infection was not considerably different across age groups (9.7-19.8%). It was higher in males compared to females (16.2 and 12.7% respectively). A significant variation was observed by nationality (7.1 to 22.2%) and municipalities (6.9-35.3%).

CONCLUSIONS:

The study provides an example of a methodologically robust approach that can be undertaken in a timely manner with limited resources. It reports much-needed epidemiological data about the spread of SARS-CoV2. Given the low prevalence rates, majority of the population in Qatar remains susceptible. Enhanced surveillance must continue to be in place, particularly due to the large number of asymptomatic cases observed. Robust contact tracing and social distancing measures are key to prevent future outbreaks.
Assuntos
Palavras-chave

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Estudo experimental / Estudo observacional / Estudo prognóstico / Ensaios controlados aleatorizados Limite: Adolescente / Adulto / Idoso / Criança / Feminino / Humanos / Masculino / Meia-Idade / Jovem adulto País/Região como assunto: Ásia Idioma: Inglês Revista: BMC Infect Dis Assunto da revista: Doenças Transmissíveis Ano de publicação: 2021 Tipo de documento: Artigo País de afiliação: S12879-021-06251-z

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Estudo experimental / Estudo observacional / Estudo prognóstico / Ensaios controlados aleatorizados Limite: Adolescente / Adulto / Idoso / Criança / Feminino / Humanos / Masculino / Meia-Idade / Jovem adulto País/Região como assunto: Ásia Idioma: Inglês Revista: BMC Infect Dis Assunto da revista: Doenças Transmissíveis Ano de publicação: 2021 Tipo de documento: Artigo País de afiliação: S12879-021-06251-z